MAS
VKTX icon

MPWM Advisory Solutions’s Viking Therapeutics VKTX Stock Holding History

MPWM Advisory Solutions’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$175K Hold
4,475
– – 0.08% 114
2026
Q1 		$146K Sell
4,475
-2,500
-36% -$80.4K 0.08% 121
2025
Q4 		$245K Sell
6,975
-250
-3% -$8.86K 0.14% 81
2025
Q3 		$190K Sell
7,225
-359
-5% -$10.7K 0.11% 91
2025
Q2 		$201K Buy
7,584
+1,885
+33% +$49.6K 0.13% 82
2025
Q1 		$138K Buy
5,699
+1,482
+35% +$46.8K 0.1% 80
2024
Q4 		$170K Buy
+4,217
New +$240K 0.12% 79

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

MPWM Advisory Solutions's VKTX Position: Q2 2026 in Review

MPWM Advisory Solutions held its Viking Therapeutics (VKTX) position steady in Q2 2026 at 4,475 shares worth $175K. The position accounts for 0.08% of the portfolio, ranked #114.

MPWM Advisory Solutions first reported a position in VKTX in Q4 2024 and has held it in 7 quarters since. The position peaked at $245K in Q4 2025. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • MPWM Advisory Solutions held 4,475 shares of Viking Therapeutics worth $175K as of Q2 2026.
  • MPWM Advisory Solutions left its Viking Therapeutics share count unchanged in Q2 2026.
  • Viking Therapeutics made up 0.08% of MPWM Advisory Solutions's portfolio in Q2 2026, its #114 holding.
  • MPWM Advisory Solutions first reported a position in Viking Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • MPWM Advisory Solutions's Viking Therapeutics position peaked at $245K in Q4 2025.
  • 432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on MPWM Advisory Solutions's 13F filing for Q2 2026, filed 13 Aug 2026.